Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Gee

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
JACC. Cardiooncology|October 4, 2021
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury: Insights Into the SENECA TrialConnor G O'Brien, Mehmet Ozgun Ozen, Gentaro Ikeda, et al.
Stem Cells (Dayton, Ohio)|September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical TrialFarhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2010
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemiaRoland Chu, Ruta Brazauskas, Fangyu Kan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
JAMA Oncology|April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.
Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
JACC. Cardiooncology|October 4, 2021
Mitochondria-Rich Extracellular Vesicles Rescue Patient-Specific Cardiomyocytes From Doxorubicin Injury: Insights Into the SENECA TrialConnor G O'Brien, Mehmet Ozgun Ozen, Gentaro Ikeda, et al.
Stem Cells (Dayton, Ohio)|September 19, 2019
Intravenous Bone Marrow Mononuclear Cells for Acute Ischemic Stroke: Safety, Feasibility, and Effect Size from a Phase I Clinical TrialFarhaan S Vahidy, Muhammad E Haque, Mohammad H Rahbar, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 2, 2010
Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemiaRoland Chu, Ruta Brazauskas, Fangyu Kan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2015
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive SarcomaNabil Ahmed, Vita S Brawley, Meenakshi Hegde, et al.
Nature Communications|July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcomaMeenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
American Heart Journal|August 10, 2010
Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and designJames T Willerson, Emerson C Perin, Stephen G Ellis, et al.
JAMA Oncology|April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.
Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Pageof 3